Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15774 articles
A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam
Afatinib demonstrated clinical effectiveness and good tolerability.
»
02/05/24
Using a combination of superb microvascular imaging and other auxiliary ultrasound techniques to increase the accuracy of gray-scale ultrasound for breast masses
Best: combination of ultrasound, strain elastography, and SMI.
»
02/16/24
AAA237, an SKP2 inhibitor, suppresses glioblastoma by inducing BNIP3-dependent autophagy through the mTOR pathway
AAA237 treatment could upregulate BNIP3 as hub gene.
»
02/10/24
IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts
IL-15 stimulation resulted in improved potency of CD70-CAR NK cells.
»
02/09/24
Novel lncRNAs LINC01221, RP11-472G21.2 and CRNDE are markers of differential expression in pediatric patients with T cell acute lymphoblastic leukemia
Distinct lncRNAs signatures noted, distinguishing T-ALL from B-ALL.
»
02/09/24
Multi-omics sequencing revealed endostar combined with cisplatin treated non small cell lung cancer via anti-angiogenesis
Restricting FMOD expression could reduce expression of FGF2, TGF-β1, VEGF and PDGF-B.
»
02/08/24
Distinguishing IDH mutation status in gliomas using FTIR-ATR spectra of peripheral blood plasma indicating clear traces of protein amyloid aggregation
Changes more pronounced in patients with IDH-mutant gliomas.
»
02/16/24
Analgesic efficacy of an opioid-free postoperative pain management strategy versus a conventional opioid-based strategy following laparoscopic radical gastrectomy: an open-label, randomized, controlled, non-inferiority trial
C-STAPB group had faster postoperative recovery profiles.
»
02/15/24
Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancer
SABR achieved satisfactory nephron sparing in severe to end-stage CKD.
»
02/15/24
Identification of CD160-TM as a tumor target on triple negative breast cancers: possible therapeutic applications
CD160-TM, but not CD160-GPI, expressed by TNBC tumor cells.
»
02/15/24
< Prev
Next >